Cargando…

Optimal target localization for subthalamic stimulation in patients with Parkinson disease

OBJECTIVE: To further determine the causes of variable outcome from deep brain stimulation of the subthalamic nucleus (DBS-STN) in patients with Parkinson disease (PD). METHODS: Data were obtained from our cohort of 309 patients with PD who underwent DBS-STN between 1996 and 2009. We examined the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Welter, Marie-Laure, Schüpbach, Michael, Czernecki, Virginie, Karachi, Carine, Fernandez-Vidal, Sara, Golmard, Jean-Louis, Serra, Giulia, Navarro, Soledad, Welaratne, Arlette, Hartmann, Andréas, Mesnage, Valérie, Pineau, Fanny, Cornu, Philippe, Pidoux, Bernard, Worbe, Yulia, Zikos, Panayiotis, Grabli, David, Galanaud, Damien, Bonnet, Anne-Marie, Belaid, Hayat, Dormont, Didier, Vidailhet, Marie, Mallet, Luc, Houeto, Jean-Luc, Bardinet, Eric, Yelnik, Jerome, Agid, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001189/
https://www.ncbi.nlm.nih.gov/pubmed/24647024
http://dx.doi.org/10.1212/WNL.0000000000000315
_version_ 1782313709665779712
author Welter, Marie-Laure
Schüpbach, Michael
Czernecki, Virginie
Karachi, Carine
Fernandez-Vidal, Sara
Golmard, Jean-Louis
Serra, Giulia
Navarro, Soledad
Welaratne, Arlette
Hartmann, Andréas
Mesnage, Valérie
Pineau, Fanny
Cornu, Philippe
Pidoux, Bernard
Worbe, Yulia
Zikos, Panayiotis
Grabli, David
Galanaud, Damien
Bonnet, Anne-Marie
Belaid, Hayat
Dormont, Didier
Vidailhet, Marie
Mallet, Luc
Houeto, Jean-Luc
Bardinet, Eric
Yelnik, Jerome
Agid, Yves
author_facet Welter, Marie-Laure
Schüpbach, Michael
Czernecki, Virginie
Karachi, Carine
Fernandez-Vidal, Sara
Golmard, Jean-Louis
Serra, Giulia
Navarro, Soledad
Welaratne, Arlette
Hartmann, Andréas
Mesnage, Valérie
Pineau, Fanny
Cornu, Philippe
Pidoux, Bernard
Worbe, Yulia
Zikos, Panayiotis
Grabli, David
Galanaud, Damien
Bonnet, Anne-Marie
Belaid, Hayat
Dormont, Didier
Vidailhet, Marie
Mallet, Luc
Houeto, Jean-Luc
Bardinet, Eric
Yelnik, Jerome
Agid, Yves
author_sort Welter, Marie-Laure
collection PubMed
description OBJECTIVE: To further determine the causes of variable outcome from deep brain stimulation of the subthalamic nucleus (DBS-STN) in patients with Parkinson disease (PD). METHODS: Data were obtained from our cohort of 309 patients with PD who underwent DBS-STN between 1996 and 2009. We examined the relationship between the 1-year motor, cognitive, and psychiatric outcomes and (1) preoperative PD clinical features, (2) MRI measures, (3) surgical procedure, and (4) locations of therapeutic contacts. RESULTS: Pre- and postoperative results were obtained in 262 patients with PD. The best motor outcome was obtained when stimulating contacts were located within the STN as compared with the zona incerta (64% vs 49% improvement). Eighteen percent of the patients presented a postoperative cognitive decline, which was found to be principally related to the surgical procedure. Other factors predictive of poor cognitive outcome were perioperative confusion and psychosis. Nineteen patients showed a stimulation-induced hypomania, which was related to both the form of the disease (younger age, shorter disease duration, higher levodopa responsiveness) and the ventral contact location. Postoperative depression was more frequent in patients already showing preoperative depressive and/or residual axial motor symptoms. CONCLUSION: In this homogeneous cohort of patients with PD, we showed that (1) the STN is the best target to improve motor symptoms, (2) postoperative cognitive deficit is mainly related to the surgery itself, and (3) stimulation-induced hypomania is related to a combination of both the disease characteristics and a more ventral STN location.
format Online
Article
Text
id pubmed-4001189
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-40011892014-05-09 Optimal target localization for subthalamic stimulation in patients with Parkinson disease Welter, Marie-Laure Schüpbach, Michael Czernecki, Virginie Karachi, Carine Fernandez-Vidal, Sara Golmard, Jean-Louis Serra, Giulia Navarro, Soledad Welaratne, Arlette Hartmann, Andréas Mesnage, Valérie Pineau, Fanny Cornu, Philippe Pidoux, Bernard Worbe, Yulia Zikos, Panayiotis Grabli, David Galanaud, Damien Bonnet, Anne-Marie Belaid, Hayat Dormont, Didier Vidailhet, Marie Mallet, Luc Houeto, Jean-Luc Bardinet, Eric Yelnik, Jerome Agid, Yves Neurology Article OBJECTIVE: To further determine the causes of variable outcome from deep brain stimulation of the subthalamic nucleus (DBS-STN) in patients with Parkinson disease (PD). METHODS: Data were obtained from our cohort of 309 patients with PD who underwent DBS-STN between 1996 and 2009. We examined the relationship between the 1-year motor, cognitive, and psychiatric outcomes and (1) preoperative PD clinical features, (2) MRI measures, (3) surgical procedure, and (4) locations of therapeutic contacts. RESULTS: Pre- and postoperative results were obtained in 262 patients with PD. The best motor outcome was obtained when stimulating contacts were located within the STN as compared with the zona incerta (64% vs 49% improvement). Eighteen percent of the patients presented a postoperative cognitive decline, which was found to be principally related to the surgical procedure. Other factors predictive of poor cognitive outcome were perioperative confusion and psychosis. Nineteen patients showed a stimulation-induced hypomania, which was related to both the form of the disease (younger age, shorter disease duration, higher levodopa responsiveness) and the ventral contact location. Postoperative depression was more frequent in patients already showing preoperative depressive and/or residual axial motor symptoms. CONCLUSION: In this homogeneous cohort of patients with PD, we showed that (1) the STN is the best target to improve motor symptoms, (2) postoperative cognitive deficit is mainly related to the surgery itself, and (3) stimulation-induced hypomania is related to a combination of both the disease characteristics and a more ventral STN location. Lippincott Williams & Wilkins 2014-04-15 /pmc/articles/PMC4001189/ /pubmed/24647024 http://dx.doi.org/10.1212/WNL.0000000000000315 Text en © 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Article
Welter, Marie-Laure
Schüpbach, Michael
Czernecki, Virginie
Karachi, Carine
Fernandez-Vidal, Sara
Golmard, Jean-Louis
Serra, Giulia
Navarro, Soledad
Welaratne, Arlette
Hartmann, Andréas
Mesnage, Valérie
Pineau, Fanny
Cornu, Philippe
Pidoux, Bernard
Worbe, Yulia
Zikos, Panayiotis
Grabli, David
Galanaud, Damien
Bonnet, Anne-Marie
Belaid, Hayat
Dormont, Didier
Vidailhet, Marie
Mallet, Luc
Houeto, Jean-Luc
Bardinet, Eric
Yelnik, Jerome
Agid, Yves
Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title_full Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title_fullStr Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title_full_unstemmed Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title_short Optimal target localization for subthalamic stimulation in patients with Parkinson disease
title_sort optimal target localization for subthalamic stimulation in patients with parkinson disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001189/
https://www.ncbi.nlm.nih.gov/pubmed/24647024
http://dx.doi.org/10.1212/WNL.0000000000000315
work_keys_str_mv AT weltermarielaure optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT schupbachmichael optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT czerneckivirginie optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT karachicarine optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT fernandezvidalsara optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT golmardjeanlouis optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT serragiulia optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT navarrosoledad optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT welaratnearlette optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT hartmannandreas optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT mesnagevalerie optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT pineaufanny optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT cornuphilippe optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT pidouxbernard optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT worbeyulia optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT zikospanayiotis optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT grablidavid optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT galanauddamien optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT bonnetannemarie optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT belaidhayat optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT dormontdidier optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT vidailhetmarie optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT malletluc optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT houetojeanluc optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT bardineteric optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT yelnikjerome optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease
AT agidyves optimaltargetlocalizationforsubthalamicstimulationinpatientswithparkinsondisease